Key clinical point: Survival following a kidney transplant did not improve as much during 2000-2018 for U.S. patients with diabetes as it did for normoglycemic patients.

Major finding: Adjusted, posttransplant mortality was 94% higher among type 1 diabetes patients and 64% higher in type 2 diabetes patients, compared with patients without diabetes.

Study details: Analysis of data collected by the United States Renal Data System during 2000-2018.

Disclosures: The study received no commercial funding. Dr. Harding had no disclosures.